Cusum-assessed personalized hypotensive treatment surveillance

D. W. Wilson, F. Halberg, Germaine G Cornelissen-Guillaume, Y. Watanabe, A. P.S. Hungin

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

An optimization approach for essential circadian timing of treatment of high blood pressure, diagnosed as one of the described vascular variability disorders, VVDs, is presented that specifically lowers the MESOR (M=Midline Estimating Statistic Of Rhythm) without inducing any other VVDs, such as CHAT (Circadian Hyper-Amplitude [A] Tension). This has been achieved using Cumulative sums and parameter tests applied to half-hourly automatic around-the-clock measurements for weeks at a time or longer. Hypotensive treatment (Rx) with a popular drug, at the wrong time was associated with CHAT, while the same dose when given at another time to the same patient was beneficial by lowering the M while leaving the 2A unaffected. In conclusion it is best to guard against an iatrogenic, excessive blood pressure overswing, systolic and/or diastolic, and against inducing other VVDs. "First do no harm" by not flying blind, i.e., by adequate surveillance of ambulatory blood pressure and heart rate measurements and concomitant sequential process control combined with statistical parameter testing.

Original languageEnglish (US)
Title of host publicationCardiovascular Health and Chronomics
PublisherNova Science Publishers, Inc.
Pages227-234
Number of pages8
ISBN (Electronic)9781631170270
ISBN (Print)9781629489766
StatePublished - Jan 1 2014

Keywords

  • Antihypertensives
  • Human BP
  • Process-control
  • Rhythmometry

Fingerprint Dive into the research topics of 'Cusum-assessed personalized hypotensive treatment surveillance'. Together they form a unique fingerprint.

Cite this